Neuroscientific Biopharmaceuticals Ltd has released a press release.
Fourth Patient Commences StemSmart MSC Treatment
Earlier from Neuroscientific Biopharmaceuticals
- 2025 Annual Report & Appendix 4E
- Previous StemSmart Studies Support Renal Transplantation
- Experienced Cell Therapy Executive Appointed CEO
- StemSmart Acquisition Complete